Tag

Contrast
23
Mar

No evidence IV contrast causes renal damage in patients with kidney disease, study finds

A new study found that chronic kidney disease (CKD) patients who received IV contrast-enhanced imaging faced no more risk of developing contrast-induced nephropathy than those who did not receive contrast material. Matt O'Connor | Diagnostic Imaging | Health Imaging

Read More

09
Sep

No gadolinium, no problem: Specialists can monitor MS patients with unenhanced MRI

Gadolinium-based contrast agents (GBCAs) are typically administered during follow-up imaging of multiple sclerosis (MS) patients. Michael Walter | Care Delivery | Radiology Business

Read More

29
Nov

Gadolinium accumulation might be more widespread than thought

Increased signal intensities in different brain regions presumably caused by linear and macrocyclic gadolinium-based contrast agents (GBCAs) could be an indication that gadolinium accumulation is more widespread than previously thought, according to a study presented on Wednesday at RSNA 2018. By Wayne Forrest, AuntMinnie.com staff writer

Read More

26
Nov

Video from RSNA 2018: What do we know about gadolinium deposition?

New findings are coming out on almost a weekly basis about trace elements of gadolinium left in human tissue after scans with MRI contrast agents. What do we know about this phenomenon, and how serious is it? We talk to Dr. Robert McDonald, PhD, of the Mayo Clinic in Rochester, MN.

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. We aim to foster a culture of excellence through collaboration with industry experts and thought leaders to deliver better outcomes.